ImpediMed

ImpediMed Fixed Asset Turnover

The Fixed Asset Turnover of ImpediMed (IPD.AX) as of Nov 12, 2026 is 14.41. In the previous year, Fixed Asset Turnover was 7.13 — a change of 102.21% (higher).

Fixed Asset Turnover

14.41

YoY

102.21%

Last updated:

Fixed Asset Turnover of ImpediMed is 2025 14.41 . Fixed Asset Turnover of ImpediMed was 2024 7.13 . It decreases by 102.21% higher compared to the previous year.

The ImpediMed Fixed Asset Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Fixed Asset Turnover
Date
Fixed Asset Turnover
Jan 1, 2018
9.02 AUD
Jan 1, 2019
22.11 AUD
Jan 1, 2020
5.66 AUD
Jan 1, 2021
8.16 AUD
Jan 1, 2022
25.28 AUD
Jan 1, 2023
5.81 AUD
Jan 1, 2024
7.13 AUD
Jan 1, 2025
14.41 AUD
The ImpediMed Fixed Asset Turnover history
YEARFixed Asset TurnoverYoY
14.41+102.21%
7.13+22.56%
5.81-77.00%
25.28+209.62%
8.16+44.34%
5.66-74.41%
22.11+145.18%
9.02-19.00%
11.13-23.88%
14.62-10.04%
16.26-6.28%
17.34—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ImpediMed Stock analysis

What does ImpediMed do? ImpediMed Ltd is an Australian company specializing in medical devices and technologies. They were founded in 1999 and have their headquarters in Brisbane, Australia. The company is a leading provider of bioimpedance measurement devices for the diagnosis, monitoring, and treatment of lymphatic, cardiac, and other medical conditions. They have a wide range of products used in various medical fields, including oncology, lymphology, and cardiology. Their main business model is based on the development and marketing of their bioimpedance measurement devices. They also provide training and support for medical personnel to optimize the use of their devices. ImpediMed specializes in the diagnosis and treatment of lymphedema in the oncology sector, particularly using their highly precise L-Dex® device. They also analyze body composition in the cardiology sector to determine the risk of heart diseases and develop personalized treatment approaches. In recent years, ImpediMed has expanded into the European market, particularly in lymphedema diagnosis and treatment. Overall, ImpediMed Ltd is an innovative company that focuses on medical devices and technologies for the diagnosis and monitoring of cardiac and lymphatic diseases. They provide important diagnostic capabilities to medical professionals and continue to focus on growth and expansion. ImpediMed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ImpediMed stock

Fixed Asset Turnover of ImpediMed is 14.41 in 2025.

Fixed Asset Turnover of ImpediMed changed from 7.13 to 14.41, representing a 102.21% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Fixed Asset Turnover ImpediMed since 2006 – with annual values, charts, and detailed analysis.

Fixed asset turnover measures revenue generated per unit of PP&E. Higher ratios indicate more efficient utilization of physical assets.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Fixed Asset Turnover's ImpediMed with sector peers and the industry average to assess whether it is attractive.

To evaluate Fixed Asset Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Fixed Asset Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — ImpediMed

All Key Metrics — ImpediMed